Amylyx Pharmaceuticals
AMLX
#6929
Rank
NZ$0.74 B
Marketcap
$8.40
Share price
-6.53%
Change (1 day)
162.49%
Change (1 year)

EPS for Amylyx Pharmaceuticals (AMLX)

EPS in 2023 (TTM): -$2.05

According to Amylyx Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.04. In 2022 the company made an earnings per share (EPS) of -$5.75 a decrease over its 2021 EPS that were of -$2.89.

EPS history for Amylyx Pharmaceuticals from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.05-64.34%
2022-$5.7598.78%
2021-$2.89